#SaludTues Tweetchat 8/20/19: Vaccination Access and Awareness

Share On Social!

Vaccinations are safe and protect the public from illness outbreaks.

Worse, vaccination hesitancy has been on the rise in America — as have the illnesses which those treatments prevent. Measles, for example, is on the rise.

This issue stems from anti-vaccination misinformation, which has spread through the internet like wildfire. This kind of information has led parents to question and, in many cases, not use this life-saving medicine.

Let’s use #SaludTues on Twitter on Tuesday, August 20, 2019, to discuss vaccinations and why they are so important for public health:

• WHAT: #SaludTues Tweetchat: “Vaccination Access and Awareness”
• TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, August 20, 2019
• WHERE: On Twitter with hashtag #SaludTues
• HOST: @SaludAmerica
• CO-HOSTS: Vaccine Ambassadors (@VaxAmbassadors), Nurses Who Vaccinate  (@NursesWhoVax), National Foundation for Infectious Diseases (@NFIDvaccines), Vaccinate Your Family (@Vaxyourfam), Within Reach (@WithinReachWA), and U.S. Dept. Health & Human Services National Vaccine Program (@HHSvaccines)

We’ll open the floor to relevant information, your stories, and collective experiences as we explore:

• How vaccination access and awareness impact Latinos, all Americans?
• Why are vaccines needed to maintain public health?
• What vaccination-access barriers do minority groups face?

Be sure to use the hashtag #SaludTues to follow the conversation on Twitter and share information, stories, and advice about clean air quality and regulation.

Click here to learn about the Salud America! #SaludTues tweetchats, see upcoming and past tweetchats — discover how you can get involved.

Editor’s Note: This tweetchat is part of a collaboration between Salud America! and the Hoffman Toxicant-Induced Loss of Tolerance (TILT) program at UT Health- San Antonio. To find out if you are experiencing TILT due to exposure from everyday foods, chemicals, or drugs, take a self-assessment or learn more about TILT.